Alzheimer Disease: all 3,765 studies

Page 36 of 38. Open to participants first (881), then studies with results posted, then the rest; newest registration first within each.

• Study Evaluating the Effect of Lecozotan SR on the QTc IntervalCompletedNCT00499642Phase 1
• Study Evaluating Safety, Tolerability, Pharmacokinetics and 5 HT1A Receptor OccupancyCompletedNCT00499200Phase 1
• Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's DiseaseCompletedNCT00495417Phase 1
• Study Comparing Lecozotan SR Two 5-mg Tablets Vs. Lecozotan SR One 10-mg Tablet in Healthy SubjectsCompletedNCT00494962Phase 1
• Clinical Trial on Alzheimer Disease, Presbycusis and Hearing AidsCompletedNCT00488007Not applicable
• A Randomized, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil in Subjects With MCICompletedNCT00483028Not applicable
• Study Evaluating the Safety,Tolerability, PK and PD of SAM-531 in the Subjects With Mild to Moderate Alzheimer's DiseaseCompletedNCT00481520Phase 2
• The Effect of Anticholinesterase Drugs on Sleep in Alzheimer's Disease PatientsCompletedNCT00480870Phase 4
• Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Young and Elderly SubjectsCompletedNCT00480818Phase 1
• Evaluation of 123-I Iodobenzovesamicol (IBVM) and SPECT Imaging of Healthy Subjects and Patients With Alzheimer DiseaseCompletedNCT00480701Phase 2
• Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315 in Healthy Japanese MalesCompletedNCT00480467Phase 1
• Specific Care and Assistance Plan for Alzheimer's DiseaseCompletedNCT00480220Not applicable
• Nutritional Programme for Dementia Elderly PatientCompletedNCT00479843Not applicable
• Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy SubjectsCompletedNCT00479700Phase 1
• Study Evaluating the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of SAM-315 in Healthy AdultsCompletedNCT00479440Phase 1
• Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531CompletedNCT00479349Phase 1
• Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Japanese MalesCompletedNCT00479297Phase 1
• Study Evaluating GSI-953 in Healthy Young and Alzheimer's PatientsCompletedNCT00479219Phase 1
• fMRI of Vulnerable Brain Regions in Persons at Risk for Alzheimer's DiseaseCompletedNCT00478491
• Posterior Cingulate Function in Persons With Risk Factors for Alzheimer's DiseaseCompletedNCT00478166
• Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315TerminatedNCT00474552Phase 1
• Study Evaluating the Safety, Tolerability and Efficacy of PBT2 in Patients With Early Alzheimer's DiseaseCompletedNCT00471211Phase 2
• A Study To Demonstrate The Bioequivalence Of Rosiglitazone XR (BRL-049653) 8mgs XR Manufactured At Two Different Sites.CompletedNCT00468897Phase 1
• Combining a Caregiver Intervention With Aricept Treatment for Mild to Moderate Alzheimer's DiseaseCompletedNCT00467766Not applicable
• PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)TerminatedNCT00459693Not applicable
• A Clinical Study to Assess Single and Repeat Doses of a New Medication (GSK933776) in Patients With Alzheimer's DiseaseCompletedNCT00459550Phase 1
• Evaluation of [123I] MNI-187 and SPECT in Patients With Alzheimers Disease in Comparison to Healthy SubjectsCompletedNCT00456417Phase 1
• A Phase I, Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's DiseaseCompletedNCT00455000Phase 1
• Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's DiseaseCompletedNCT00454870Phase 2
• Single Ascending Dose Study of SRA-444 in Healthy SubjectsCompletedNCT00452504Phase 1
• Evaluation of [123I] AV83 and SPECT in Patients With Alzheimer Disease in Comparison to Healthy ControlsCompletedNCT00448799Phase 1
• Evaluating the Effects of Music Interventions on Hospitalised People With DementiaStatus unknownNCT00448318Phase 2/3
• A Trial of SK-PC-B70M in Mild to Moderate Alzheimer's DiseaseCompletedNCT00443417Phase 2
• The Dementia Study in Northern NorwayCompletedNCT00443014Phase 4
• Effects of Doxycycline and Rifampicin on Biomarkers of Alzheimer's Disease in the Cerebrospinal FluidCompletedNCT00439166Phase 3
• Use of [123I] AV39 and SPECT Imaging as a Marker of Protein Disposition in Subjects With Alzheimer Disease Compared to Healthy SubjectsCompletedNCT00439010Phase 1
• Couples Coping With Alzheimer's DiseaseStatus unknownNCT00438724Not applicable
• SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)CompletedNCT00438568Phase 2
• Effect of Indomethacin on the Progression of Alzheimer's DiseaseCompletedNCT00432081Phase 3
• Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's DiseaseCompletedNCT00423228Not applicable
• GTS21-201 for Alzheimer Disease:GTS-21 Administered Daily for 28 Days to Participants With Probable Alzheimer's DiseaseCompletedNCT00414622Phase 2
• MRI of Alzheimer's Disease Imaging Amyloid Plaques in Persons With and Without Memory ProblemsCompletedNCT00413621
• Functional Magnetic Resonance Imaging - Synthetic Aperture Magnetometry (fMRI-SAM) and Alzheimer's DiseaseWithdrawnNCT00412048Not applicable
• Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)CompletedNCT00411580Phase 1
• An Innovative Psychosocial Intervention for Adult-Child Caregivers of Parents With Alzheimer's DiseaseStatus unknownNCT00409279Not applicable
• Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's DiseaseCompletedNCT00408525Phase 1
• PET Imaging of Brain Amyloid Using [11C]MeS-IMPYCompletedNCT00407576Phase 1
• Hippocampus Study: Comparative Effect of Donepezil 10mg/d and Placebo on Clinical and Radiological MarkersCompletedNCT00403520Phase 4
• Exercise Treatment of Mild-Stage Probable Alzheimer's DiseaseCompletedNCT00403507Phase 2
• Memantine for Agitation and Aggression in Severe Alzheimer's DiseaseCompletedNCT00401167Phase 4
• Effect of Testosterone Therapy in Men With Alzheimer's Disease and Low TestosteroneCompletedNCT00392912Not applicable
• Effect of Panax Ginseng on the Cognitive Performance in Alzheimer's DiseaseCompletedNCT00391833Phase 1/2
• Efficacy of Early Stage Alzheimer's Support GroupsCompletedNCT00391794Not applicable
• Enhancing Quality of Life for Nursing Home ResidentsCompletedNCT00388544Phase 2
• Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With AriceptCompletedNCT00384423Phase 2
• Activity of AVE1625 in Mild to Moderate Alzheimer's Patients.CompletedNCT00380302Phase 1/2
• Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 ProtocolTerminatedNCT00380276Phase 3
• Double-blind, Placebo-controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's DiseaseCompletedNCT00377715Phase 2
• Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementia PatientsWithdrawnNCT00375557Phase 4
• Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease PatientsTerminatedNCT00369603Phase 4
• Study Evaluating the Safety of Lecozotan SR in Healthy Young and Elderly SubjectsCompletedNCT00366483Phase 1
• Study Evaluating PAZ-417 in Healthy Young/ElderlyCompletedNCT00366288
• Comprehensive Support for Alzheimer's Disease CaregiversCompletedNCT00362284Not applicable
• MK0952 in Patients With Mild-to-Moderate Alzheimer's Disease (0952-004)(COMPLETED)TerminatedNCT00362024Phase 2
• European Study of HF0220 in Mild to Moderate Alzheimer's Disease PatientsCompletedNCT00357357Phase 2
• Amyloid Plaque and Tangle Imaging in Aging and DementiaCompletedNCT00355498
• SB-742457 And Donepezil In Alzheimer's DiseaseCompletedNCT00348192Phase 2
• Safety and Efficacy of High Dose, Rapid Titration Galantamine in Patients With Alzheimer's DiseaseCompletedNCT00338117Phase 3
• Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease)CompletedNCT00334906Phase 4
• Effects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers DiseaseTerminatedNCT00334568Phase 2
• Effects of LY2062430 in Subjects With Mild-to-Moderate Alzheimer's Disease and in Healthy VolunteersCompletedNCT00329082Phase 2
• Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's DiseaseCompletedNCT00325728Phase 2
• Global Efficacy Study of MPC-7869 to Treat Patients With Alzheimer'sTerminatedNCT00322036Phase 3
• Computer-Based Training for Mild Alzheimer's DiseaseCompletedNCT00319891Phase 1
• Memory Imaging of Normal AgingCompletedNCT00315575
• Open-Label Extension of the Phase III Study With Tramiprosate (3APS) in Patients With Mild to Moderate Alzheimer's DiseaseStatus unknownNCT00314912Phase 3
• A Cardiac Safety Study of Galantamine in the Treatment of Alzheimer's Disease.CompletedNCT00309725Phase 3
• Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive ImpairmentStatus unknownNCT00306124Phase 4
• Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's DiseaseCompletedNCT00305903Phase 4
• Long-term Safety and Efficacy of Galantamine in Alzheimer's DiseaseCompletedNCT00304629Phase 3
• Do HMG CoA Reductase Inhibitors Affect Abeta Levels?CompletedNCT00303277Phase 4
• An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease.CompletedNCT00301574Phase 3
• An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-month PeriodCompletedNCT00299676
• A Study of the Safety and Effectiveness of Galantamine Hydrobromide in Patients With Alzheimer's DiseaseCompletedNCT00297362
• Effects of Community Occupational Therapy in Older Patients With Dementia and Their Caregivers.Status unknownNCT00295152Not applicable
• Enhancing Care Coordination: Hospital to Home for Cognitively Impaired Older Adults and Their CaregiversCompletedNCT00294307
• A Survey Study of the Treatment and Outcome Management in Patients Diagnosed With Alzheimer's DiseaseCompletedNCT00291421
• A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's DiseaseTerminatedNCT00287742Phase 3
• Assess 123-I IMPY and SPECT Imaging as a Tool to Detect β-Amyloid in the BrainCompletedNCT00287248Phase 1
• Long-Term Safety Extension With SR57667B in Patients With Alzheimer's DiseaseCompletedNCT00285077Phase 2
• Study of the Effect of SR57667B in Patients With Alzheimer's DiseaseCompletedNCT00285025Phase 2
• Use of Different Treatment Care Methods in Patients With Dementia Associated With Alzheimer's DiseaseCompletedNCT00283725
• Telephone Call From Acute Care Physicians to Long Term Care Physicians: Impact on Transitional Care of Elderly PatientsCompletedNCT00281749Phase 1
• Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's DiseaseCompletedNCT00277810Phase 2/3
• A Study of EGb 761® (Tanakan®) in Dementia of Alzheimer Type Onset in Patients Suffering From Memory ComplaintsCompletedNCT00276510Phase 4
• Brain Aging Project--Kansas UniversityCompletedNCT00267124
• A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed DementiaCompletedNCT00261573Phase 3
• Escitalopram Treatment of Patients With Agitated DementiaCompletedNCT00260624Phase 4
• Project ACT: Advancing Caregiving TechniquesCompletedNCT00259480Phase 3
• Project TAP: Tailored Activities ProjectCompletedNCT00259467Phase 1

← Alzheimer Disease overview